Clinical Trial Update: Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial results comparing MEM 1003 to placebo in Bipolar I Disorder, reporting safety and efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• MEM 1003

Snippet

Sponsor: Memory Pharmaceuticals | Conditions: Bipolar Disorder With Manic or Mixed Episodes | Phase 2 | Status: COMPLETED